Close Menu

NEW YORK – Biocept on Friday filed a shelf registration to publicly offer up to $100 million in a mix of securities.

The San Diego-based firm said in a document filed with the US Securities and Exchange Commission that it plans to offer from time to time securities that include shares of its common stock and preferred stock, various series of debt securities, and warrants to purchase any of such securities.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.